Valsartan
Valsartan NDMA Contamination Class Action Lawsuit: Claims Not Open
People who paid for valsartan drugs between January 1, 2012 and November 10, 2021 may be in this class action lawsuit. Follow the case.
- Possible recovery
- Up to $50
Not a settlement payment. Depends on the case outcome.
- Claim deadline
- TBD
- Proof requirement
- TBD
Eligibility
Who may qualify?
Check the covered dates, products, locations, and other official terms before you file.
- You paid any amount of money for a valsartan-containing drug between January 1, 2012 and November 10, 2021.
- You bought the drug for personal or household use.
- One of the manufacturer defendants made the drug, and a defendant sold or distributed it in the United States.
- If your drug was made by Hetero or Camber, only purchases on or after May 1, 2018 count.
Case overview
What is the Valsartan case about?
A certified class action is moving forward against ZHP, Teva, Mylan, Aurobindo, CVS, Walmart and other drug makers, pharmacies and wholesalers, alleging that generic valsartan blood pressure medications, including Valsartan HCTZ, Amlodipine Valsartan and Amlodipine Valsartan HCTZ, were contaminated with NDMA and NDEA, chemicals described as probable human carcinogens. The companies named in the suit deny any wrongdoing.
You may fall within the certified classes if you paid out of pocket for a valsartan-containing drug for personal or household use anytime between January 1, 2012 and November 10, 2021, or if you took enough of the affected medication to qualify for ongoing medical monitoring. While the court has certified these classes, the case itself has not yet settled, so there is no money available at this time. Should a settlement or other benefits materialize down the road, those who qualify will likely need to submit a claim along with supporting evidence.
Questions people ask
Frequently asked questions
How much could the Valsartan case pay?
The listed potential recovery is Up to $50. This is not a settlement payment. Any recovery depends on how the case is resolved.
Who qualifies for the Valsartan case?
Key eligibility criteria include: You paid any amount of money for a valsartan-containing drug between January 1, 2012 and November 10, 2021; You bought the drug for personal or household use; One of the manufacturer defendants made the drug, and a defendant sold or distributed it in the United States; If your drug was made by Hetero or Camber, only purchases on or after May 1, 2018 count. Always confirm the details with the sources on this page.
Is the Valsartan case a settlement?
No. This is a lawsuit that has not been resolved, and no court has approved a settlement, so there is no settlement fund or official claim form. Be cautious of any site asking you to file or pay for it today.
Is the Valsartan case open?
No claim process is open, because there is no settlement. TapClaim monitors the case for updates.
Sources
- OrganizationEisnerAmper
- Case websiteCase websiteVisit case websitePrimary source
- Listing verificationLast checked Nov 10, 2026
